The art of ophthalmology

Article

This article highlights a photo competition from countries across the globe.

Photographs are usually taken in ophthalmology to verify diagnosis, detect diseases or to document the progression over time. Researchers interested in the network and anatomical structures of the eye use histological and sophisticated imaging techniques to elucidate the complex interactions of the cells involved.

However, in addition to the clinical and scientific benefit of these pictures, they are also aesthetic treasures. The beauty of these pictures often blurs the border between documenting science and art. We know pieces of art with ophthalmological motives such as famous paintings including 'The Parable of the Blind' by Pieter Bruegel (1568), 'The blind sister' by Paula Modersohn-Becher (1903) and 'The Blind' by Egon Schiele (1913) just to mention a few.

Fascinated by photography

Overwhelming response

Taking a closer look at the winning photos (Figures 1–5) it is obvious that three categories are evident: The 'investigation' category is the result of seeking what is imagined but not yet shown. The 'clinical' category is the encounter between pathology and an attentive photographer. Lastly, in the 'artistic' category, there is a search of beauty in the teaching of ophthalmology.

The cooperation with Heidelberg Engineering is a rare stroke of luck for the European Vision Institute to enable the implementation of an activity, which demonstrates the inherent beauty of the work by colleagues of the worldwide ophthalmological community. Our particular thanks also go to the numerous photographers around the world, who permit us to enjoy the beauty and fascination of ophthalmology.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.